• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高粪便免疫化学试验在苏格兰肠道筛查计划中检测血红蛋白的应用。

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme.

机构信息

Centre for Research into Cancer Prevention and Screening, University of Dundee, Dundee, Dundee, Scotland, UK.

Public Health Scotland, Edinburgh, Scotland, UK.

出版信息

J Med Screen. 2023 Dec;30(4):184-190. doi: 10.1177/09691413231175611. Epub 2023 May 25.

DOI:10.1177/09691413231175611
PMID:37229658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10629250/
Abstract

OBJECTIVES

This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer.

METHODS

Data were collected for all individuals invited to participate in the Scottish Bowel Screening Programme between November 2017 and March 2018 including faecal haemoglobin concentration, age, sex, National Health Service Board, socioeconomic status, and screening history. Linkage with The Scottish Cancer Registry identified all screening participants diagnosed with colorectal cancer. Logistic regression was performed to identify which factors demonstrated significant association with colorectal cancer and could be used in the development of a risk-scoring model.

RESULTS

Of 232,076 screening participants, 427 had colorectal cancer: 286 diagnosed following a screening colonoscopy and 141 arising after a negative screening test result giving an interval cancer proportion of 33.0%. Only faecal haemoglobin concentration and age showed a statistically significant association with colorectal cancer. Interval cancer proportion increased with age and was higher in women (38.1%) than men (27.5%). If positivity in women were mirrored in men at each age quintile interval cancer proportion would still have remained higher in women (33.2%). Moreover, an additional 1201 colonoscopies would be required to detect 11 colorectal cancers.

CONCLUSIONS

Development of a risk scoring model using early data from the Scottish Bowel Screening Programme was not feasible due to most variables showing insignificant association with colorectal cancer. Tailoring the faecal haemoglobin concentration threshold according to age could help to diminish some of the disparity in interval cancer proportion between women and men. Strategies to achieve sex equality using faecal haemoglobin concentration thresholds depend considerably on which variable is selected for equivalency and this requires further exploration.

摘要

目的

本研究旨在建立苏格兰结直肠筛查计划中的风险评分模型,将粪便血红蛋白浓度与结直肠癌的其他危险因素结合起来。

方法

收集了 2017 年 11 月至 2018 年 3 月期间所有受邀参加苏格兰结直肠筛查计划的个体的数据,包括粪便血红蛋白浓度、年龄、性别、国民保健制度委员会、社会经济地位和筛查史。与苏格兰癌症登记处的链接确定了所有筛查参与者中被诊断为结直肠癌的患者。采用逻辑回归确定哪些因素与结直肠癌有显著关联,并可用于开发风险评分模型。

结果

在 232076 名筛查参与者中,有 427 人患有结直肠癌:286 人在筛查结肠镜检查后确诊,141 人在阴性筛查结果后出现,间隔期癌症比例为 33.0%。只有粪便血红蛋白浓度和年龄与结直肠癌有统计学显著关联。间隔期癌症比例随年龄增长而增加,女性(38.1%)高于男性(27.5%)。如果女性的阳性率在每个年龄五分位数间隔期内都与男性相同,那么女性的间隔期癌症比例仍将高于男性(33.2%)。此外,还需要额外进行 1201 次结肠镜检查才能发现 11 例结直肠癌。

结论

由于大多数变量与结直肠癌的关联不显著,因此使用苏格兰结直肠筛查计划的早期数据开发风险评分模型是不可行的。根据年龄调整粪便血红蛋白浓度阈值可能有助于减少女性和男性之间间隔期癌症比例的差异。使用粪便血红蛋白浓度阈值实现性别平等的策略在很大程度上取决于选择哪个变量作为等效性,这需要进一步探讨。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ee/10629250/15081a7f1d75/10.1177_09691413231175611-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ee/10629250/15081a7f1d75/10.1177_09691413231175611-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5ee/10629250/15081a7f1d75/10.1177_09691413231175611-fig1.jpg

相似文献

1
Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme.提高粪便免疫化学试验在苏格兰肠道筛查计划中检测血红蛋白的应用。
J Med Screen. 2023 Dec;30(4):184-190. doi: 10.1177/09691413231175611. Epub 2023 May 25.
2
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.基于粪便免疫化学检测的全国性结直肠癌筛查项目中的间期癌:对粪便血红蛋白浓度阈值及性别不平等的影响
J Med Screen. 2024 Mar;31(1):21-27. doi: 10.1177/09691413231188252. Epub 2023 Jul 19.
3
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.在国家筛查计划中诊断为结直肠癌的男性和女性的粪便血红蛋白浓度。
J Med Screen. 2022 Mar;29(1):26-31. doi: 10.1177/09691413211056970. Epub 2021 Nov 22.
4
Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.当结肠镜检查能力有限时,使用定量粪便免疫化学试验(FIT)检测血红蛋白来筛查间隔期癌。
J Med Screen. 2016 Sep;23(3):130-4. doi: 10.1177/0969141315609634. Epub 2015 Nov 19.
5
Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.粪便血红蛋白浓度与下一轮筛查中晚期结直肠肿瘤的检测有关。
J Med Screen. 2017 Jun;24(2):62-68. doi: 10.1177/0969141316653983. Epub 2016 Jul 1.
6
Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies.按性别、年龄、贫困程度和地理区域划分的粪便血红蛋白分布:对结直肠癌筛查策略的影响。
Clin Chem Lab Med. 2020 Nov 26;58(12):2073-2080. doi: 10.1515/cclm-2020-0268.
7
Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?使用粪便免疫化学检测的基于人群的结直肠癌筛查项目:粪便血红蛋白临界值应因年龄和性别而异吗?
BMC Cancer. 2017 Aug 29;17(1):577. doi: 10.1186/s12885-017-3555-3.
8
Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.在英国国民医疗服务体系(NHS)肠癌筛查项目中,与愈创木脂粪便潜血试验相比,不同阳性阈值下粪便免疫化学检测的成本效益。
BMJ Open. 2017 Oct 27;7(10):e017186. doi: 10.1136/bmjopen-2017-017186.
9
Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.两种粪便免疫化学检测试验在不同阳性截断值下检测晚期肿瘤的性能:荷兰国家结直肠癌筛查计划的一项横断面研究。
Lancet Gastroenterol Hepatol. 2019 Feb;4(2):111-118. doi: 10.1016/S2468-1253(18)30319-4. Epub 2018 Nov 27.
10
Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies.粪便免疫化学检测在结直肠癌筛查中的应用:不同诊断策略的结果评估。
J Med Screen. 2021 Sep;28(3):277-285. doi: 10.1177/0969141320980501. Epub 2020 Dec 20.

引用本文的文献

1
Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT-based colorectal cancer screening.达到筛查年龄上限后的间期癌风险:基于粪便免疫化学检测的结直肠癌筛查中的风险分层告知
Int J Cancer. 2025 May 1;156(9):1783-1790. doi: 10.1002/ijc.35294. Epub 2024 Dec 19.

本文引用的文献

1
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.阴性粪便免疫化学检测(FIT)后与结直肠癌间隔期相关的因素:荷兰基于 FIT 的 CRC 筛查计划中两次筛查轮次的结果。
Int J Cancer. 2023 Apr 15;152(8):1536-1546. doi: 10.1002/ijc.34373. Epub 2022 Dec 1.
2
Do faecal test-based colorectal cancer screening pilots provide data that are reflected in subsequent programmes? Evidence from interval cancer proportions.基于粪便检测的结直肠癌筛查试验是否提供了后续计划中反映的数据?来自间隔期癌症比例的证据。
Ann Clin Biochem. 2022 Nov;59(6):450-452. doi: 10.1177/00045632221119714. Epub 2022 Aug 27.
3
Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening.
基于粪便免疫化学试验的结直肠癌筛查中降低女性当前劣势的策略。
Clin Chem Lab Med. 2022 Jul 13;60(10):1496-1505. doi: 10.1515/cclm-2022-0583. Print 2022 Sep 27.
4
A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.比较四种不同粪便免疫化学检测系统报告的疑似结直肠癌和严重肠道疾病患者的粪便血红蛋白浓度和诊断准确性。
Clin Chem Lab Med. 2022 Jun 1;60(8):1278-1286. doi: 10.1515/cclm-2021-1248. Print 2022 Jul 26.
5
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.粪便潜血丢失准确预测结直肠癌的未来检出。一种预后模型。
Gut. 2023 Jan;72(1):101-108. doi: 10.1136/gutjnl-2022-327188. Epub 2022 May 10.
6
Optimizing screening with faecal immunochemical test for both sexes - Cost-effectiveness analysis from Finland.优化男女粪便免疫化学检测筛查 - 来自芬兰的成本效益分析。
Prev Med. 2022 Apr;157:106990. doi: 10.1016/j.ypmed.2022.106990. Epub 2022 Feb 9.
7
Risk-stratified selection to colonoscopy in FIT colorectal cancer screening: development and temporal validation of a prediction model.基于 FIT 的结直肠癌筛查中对结肠镜检查的风险分层选择:预测模型的开发和时间验证。
Br J Cancer. 2022 May;126(8):1229-1235. doi: 10.1038/s41416-022-01709-6. Epub 2022 Jan 20.
8
Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the "interval cancer" perspective.从“间期癌”角度优化比利时佛兰德斯的粪便免疫化学试验(FIT)结直肠癌筛查方案。
Br J Cancer. 2022 Apr;126(7):1091-1099. doi: 10.1038/s41416-021-01694-2. Epub 2022 Jan 12.
9
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.在国家筛查计划中诊断为结直肠癌的男性和女性的粪便血红蛋白浓度。
J Med Screen. 2022 Mar;29(1):26-31. doi: 10.1177/09691413211056970. Epub 2021 Nov 22.
10
Varying fecal immunochemical test screening cutoffs by age and gender: a way to increase detection rates and reduce the number of colonoscopies.按年龄和性别调整粪便免疫化学检测筛查切点:提高检出率和减少结肠镜检查数量的一种方法。
Gastrointest Endosc. 2022 Mar;95(3):540-549. doi: 10.1016/j.gie.2021.09.038. Epub 2021 Oct 6.